Online Retailer Vapkit Launches Get Healthy Rotherham Smoking Cessation Service

Aug.31.2022
Online Retailer Vapkit Launches Get Healthy Rotherham Smoking Cessation Service
Vapkit launches Get Healthy Rotherham, a quit smoking service for 39,487 smokers in one of the worst-supported areas in England.

Online retailer Vapkit has launched a quit smoking service called Get Healthy Rotherham, which aims to help 39,487 smokers quit traditional cigarettes. The company's research found that the North of England is one of the worst areas in the UK for smokers to access local support to quit.


According to a study by Vapekit, England has nearly 500,000 adult smokers who are unable to access local support services to quit smoking. The Rotherham area is among the worst, with only one service available to help almost 40,000 smokers.


Negative news reports have rocked the local council and the Rotherham NHS Foundation Trust Fund. The Director of Public Health for Rotherham stated that throughout the year, the committee has been engaging with residents to promote healthier lifestyles and providing advice on quitting smoking through existing services. Over the past few years, the hard work of Rotherham Hospital's maternity ward has resulted in a remarkable increase in the number of pregnant mothers who have quit smoking.


It is important to understand that quitting smoking is a very personal process for many people. Some may use over-the-counter nicotine products and e-cigarettes to quit, while others have found success with online support such as the NHS quit smoking app.


The Rothwell NHS Foundation Trust has announced that it is fully committed to helping smokers quit and has recently added outpatient patients to its list of potential clients.


A spokesperson for the Department of Health and Social Care told Rothwell Advertisers, "Tackling smoking is a key part of the government's agenda and that's why we've launched an independent review of the England Tobacco Control Plan 2030.


According to a comprehensive study by Vapekit, the cities in the UK with the highest number of adult smokers often have the worst smoking cessation support services. A spokesperson for Vapekit stated that "quitting smoking remains the only preventable cause of death in the UK, resulting in approximately 78,000 fatalities annually. The NHS spends £3.6 billion on medical and social care, with an estimated social cost of £17 billion - £5 billion more than previously calculated - due to individuals who have died from smoking-related diseases, such as cancer, being unable to work.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The translation of this article is solely for communication and research purposes within the industry.


Due to limitations in translation ability, the translated article may not fully reflect the same meaning as the original. Please refer to the original text for accuracy.


2FIRSTS maintains full alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related expressions and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Renews Exposure Modification Authorization for IQOS Devices and Three HeatSticks Products
FDA Renews Exposure Modification Authorization for IQOS Devices and Three HeatSticks Products
U.S. Food and Drug Administration renewed modified risk granted orders for five IQOS products from Philip Morris Products S.A., including two IQOS system holders and chargers and three HeatSticks products. Under the renewed orders, the products may continue to be marketed with an exposure modification claim.
Apr.20 by 2FIRSTS.ai
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Haypp Group reported a 40% year-on-year increase in nicotine pouch volumes in the first quarter of 2026, with U.S. and U.K. volumes rising 123% and 102%, respectively. Haypp says around 97% of its consumer traffic is organic and that its Media & Insights business provides brand owners with on-site visibility, trial activation and consumer intelligence. For international tobacco companies, Haypp may be both a growth partner for modern oral products and a new source of channel leverage.
Special Report
May.22
FEELM Releases Four Transparent Pod-Related Solutions for the TPD Market
FEELM Releases Four Transparent Pod-Related Solutions for the TPD Market
FEELM, a technology brand under Smoore, released four product solutions at an industry expo held in France, including OMNI POD MINI, OMNI POD MAX, TWINBREEZE, and CRYSBERG. The solutions are designed around TPD market needs and involve transparent pod design, leak-resistant structures, flavor performance, smart recognition, and different capacity configurations.
Apr.09 by 2FIRSTS.ai
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes
South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes
South Korea’s Ministry of Food and Drug Safety said on April 17 that it has additionally designated the International Characterization Research Institute as a tobacco harmful components testing body under the Act on the Management of Tobacco Harmfulness. The institute has research experience in analyzing harmful components in liquid e-cigarettes and has obtained recognition for tobacco-sector ISO 17025 requirements.
Apr.17 by 2FIRSTS.ai
California Bill Would Let Schools Include Nicotine in Student-Athlete Drug Screens
California Bill Would Let Schools Include Nicotine in Student-Athlete Drug Screens
California lawmakers are advancing a bill that would allow schools with existing student-athlete drug testing programs to include nicotine in those screenings.
Apr.09 by 2FIRSTS.ai